Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Fuguan Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Wuhan, China, specializing in the research, development, and manufacturing of small molecule drugs. Established in 2002, the company produces a variety of pharmaceutical forms, including tablets, capsules, and granules, as well as Active Pharmaceutical Ingredients (APIs). Its product portfolio is primarily focused on therapeutic areas such as cardiovascular health, respiratory medicine, and anti-infectives. Fuguan Pharmaceutical operates modern, GMP-certified facilities and is recognized as a high-tech enterprise within Hubei Province. The company serves the domestic Chinese healthcare market while also engaging in international trade of its pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Fuguan Pharmaceutical.